v3.25.2
EQUITY (Tables)
6 Months Ended
Jun. 30, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Changes In Consolidated Equity
The following tables present the changes in consolidated equity (dollars in millions, share amounts in thousands):
Common StockAdditional
Paid-In
Capital
Accumulated
Other
Comprehensive
Loss
Retained EarningsTreasury
Stock
Noncontrolling
Interests
Total Equity
Shares
Outstanding
Issued Par
Amount
Balances at December 31, 202495,109 $8 $4,873 $(180)$3,008 $(3,538)$1,649 $5,820 
Net income— — — — 406 — 95 501 
Distributions paid to noncontrolling interests— — — — — — (89)(89)
Other comprehensive income— — — — — — 
Net purchases (sales) of businesses and noncontrolling interests— — (35)— — — 41 
Repurchases of common stock(2,629)— — — — (351)— (351)
Stock-based compensation expense, tax benefit and issuance of common stock405 — (12)— — — — (12)
Balances at March 31, 202592,885 8 4,826 (178)3,414 (3,889)1,696 5,877 
Net income— — — — 288 — 105 393 
Distributions paid to noncontrolling interests— — — — — — (83)(83)
Other comprehensive income— — — — — — 
Net purchases of businesses and noncontrolling interests— — 10 — — — 19 
Repurchases of common stock(4,601)— — — — (753)— (753)
Stock-based compensation expense, tax benefit and issuance of common stock60 — 22 — — — — 22 
Balances at June 30, 202588,344 $8 $4,858 $(177)$3,702 $(4,642)$1,727 $5,476 
Common StockAdditional
Paid-In
Capital
Accumulated
Other
Comprehensive
Loss
Retained Earnings
(Accumulated
Deficit)
Treasury
Stock
Noncontrolling
Interests
Total Equity
Shares
Outstanding
Issued Par
Amount
Balances at December 31, 202399,950 $8 $4,834 $(181)$(192)$(2,861)$1,509 $3,117 
Net income— — — — 2,151 — 82 2,233 
Distributions paid to noncontrolling interests— — — — — — (78)(78)
Other comprehensive income— — — — — — 
Net sales of businesses and noncontrolling interests— — (5)— — — (23)(28)
Repurchases of common stock(2,811)— — — — (280)— (280)
Stock-based compensation expense, tax benefit and issuance of common stock534 — (23)— — — — (23)
Balances at March 31, 202497,673 8 4,806 (179)1,959 (3,141)1,490 4,943 
Net income— — — — 259 — 97 356 
Distributions paid to noncontrolling interests— — — — — — (70)(70)
Other comprehensive income— — — — — — 
Net purchases of businesses and noncontrolling interests— — 12 — — — 64 76 
Repurchases of common stock(1,990)— — — — (273)— (273)
Stock-based compensation expense and issuance of common stock136 — 22 — — — — 22 
Balances at June 30, 202495,819 $8 $4,840 $(177)$2,218 $(3,414)$1,581 $5,056 
Schedule of Changes in Redeemable Noncontrolling Interests in Equity of Consolidated Subsidiaries
The table below presents our nonredeemable noncontrolling interests balances by segment:
 June 30, 2025December 31, 2024
Hospital Operations$215 $205 
Ambulatory Care1,512 1,444 
Total nonredeemable noncontrolling interests$1,727 $1,649 
The table below presents our income available to nonredeemable noncontrolling interests by segment:
 Three Months Ended
June 30,
Six Months Ended
June 30,
 2025202420252024
Hospital Operations$12 $12 $24 $21 
Ambulatory Care93 85 176 158 
Total net income available to nonredeemable noncontrolling interests
$105 $97 $200 $179 
Schedule of Share Repurchase Activity
The table below presents repurchase activity under both the 2022 and 2024 share repurchase programs:
PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Program
Maximum Dollar Value of Shares That May Yet Be Purchased Under the Program(1)
 (In Thousands)(In Thousands)(In Millions)
Six Months Ended June 30, 2025:
January 1 through January 31, 2025$— $1,376 
February 1 through February 28, 20251,800$134.98 1,800$1,133 
March 1 through March 31, 2025829$126.67 829$1,028 
April 1 through April 30, 2025$— $1,028 
May 1 through May 31, 20252,456$157.57 2,456$641 
June 1 through June 30, 20252,145$167.83 2,145$281 
January 1 through June 30, 20257,230$151.45 7,230
Six Months Ended June 30, 2024:
January 1 through January 31, 2024$— $550 
February 1 through February 29, 2024$— $550 
March 1 through March 31, 20242,811$98.86 2,811$272 
April 1 through April 30, 2024$— $272 
May 1 through May 31, 2024$— $272 
June 1 through June 30, 20241,990$135.85 1,990$
January 1 through June 30, 20244,801$114.19 4,801
(1)
In July 2025, our board of directors authorized a $1.500 billion increase to the 2024 share repurchase program. With this new authorization, $1.781 billion was available for repurchases of our common stock as of July 22, 2025.